Appeal No. 95-2484 Application 07/948,470 lipoproteins from patients having familial hypercholesterolemia using substantially the same method. As to the § 101 rejection, we find that the examiner has proffered several theories as to why he believes one skilled in the art would question the objective truth of the statement of utility. Some of these theories are said to be based on the teachings of various references; i.e., Kato, Margulis and Lehninger. However, we find that the examiner has not applied the legal standard correctly. Since of the cited references, Lehninger does not teach patients having the claimed disease; i.e., amyloidosis, and Kati and Margulis, do not teach the appellants’ method of treating amyloidosis, there is no evidence of record that one skilled in the art would have arrived at the same conclusions as the examiner. Thus, although proffered under the guise “scientific reasoning,” the examiner’s theories are undeniably speculative. The decision of the examiner is reversed. REVERSED WILLIAM F. SMITH ) Administrative Patent Judge ) ) ) JOAN ELLIS ) BOARD OF PATENT Administrative Patent Judge ) APPEALS AND ) INTERFERENCES ) DOUGLAS W. ROBINSON ) Administrative Patent Judge ) 5Page: Previous 1 2 3 4 5 6 7 NextLast modified: November 3, 2007